1958
DOI: 10.1017/s0022215100053615
|View full text |Cite
|
Sign up to set email alerts
|

Some Clinicopathological Observations On Scleroma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
4
0

Year Published

1960
1960
2013
2013

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 23 publications
(4 citation statements)
references
References 8 publications
0
4
0
Order By: Relevance
“…It affects the nose, naso-pharynx, larynx and trachea usually in combination but according to Dobrzafiski it may be limited to the trachea (Dobrzafiski, 1951). Handousa and Elwi (1958) state that the granuloma when fully developed may present as either multiple well localized small masses or as a single large tumourlike structure. Pressure atrophy of underlying bone particularly in the nose may occur.…”
Section: Discussionmentioning
confidence: 99%
“…It affects the nose, naso-pharynx, larynx and trachea usually in combination but according to Dobrzafiski it may be limited to the trachea (Dobrzafiski, 1951). Handousa and Elwi (1958) state that the granuloma when fully developed may present as either multiple well localized small masses or as a single large tumourlike structure. Pressure atrophy of underlying bone particularly in the nose may occur.…”
Section: Discussionmentioning
confidence: 99%
“…The countries mainly concerned are Poland, Hungary, South-Western Russia, Central America, Indonesia and Egypt. In the latter country Handousa (1958) reports an average of 40 cases seen per annum at one hospital. And it is characteristic of this disease that within these countries, the rhinoscleromatous areas tend to remain well-defined and often quite small.…”
Section: Geographic Distributionmentioning
confidence: 99%
“…Scleroma is a chronic granulomatous disease endemic in Egypt amongst many other countries. An average of 40 cases are seen per year at one hospital as reported by Handousa and Elwi (1958). It has a gradual onset affecting the upper respiratory tract, usually in the nose and extending gradually backwards into the pharynx, larynx and sometimes the trachea and bronchi (Friedmann et al, 1986).…”
Section: Introductionmentioning
confidence: 99%